Attached files
| file | filename |
|---|---|
| EX-23.1 - EXHIBIT 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Syneos Health, Inc. | exhibit231_consentxey.htm |
| 10-K - FORM 10-K - Syneos Health, Inc. | a2017form10-k.htm |
| EX-32.2 - EXHIBIT 32.2 SECTION 906 CFO CERTIFICATION - Syneos Health, Inc. | exhibit322section906cfo_q4.htm |
| EX-32.1 - EXHIBIT 32.1 SECTION 906 CEO CERTIFICATION - Syneos Health, Inc. | exhibit321section906ceo_q4.htm |
| EX-31.2 - EXHIBIT 31.2 SECTION 302 CFO CERTIFICATION - Syneos Health, Inc. | exhibit312section302cfo_q4.htm |
| EX-31.1 - EXHIBIT 31.1 SECTION 302 CEO CERTIFICATION - Syneos Health, Inc. | exhibit311section302ceo_q4.htm |
| EX-21.1 - EXHIBIT 21.1 SIGNIFICANT SUBSIDIARIES OF REGISTRANT - Syneos Health, Inc. | exhibit211_significantsubs.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-219607, 333-212154, and 333-199960 on Form S-8 and No. 333-208286 on Form S-3 of our reports dated February 28, 2018, relating to the consolidated financial statements of Syneos Health, Inc. (formerly INC Research Holdings, Inc.) and its subsidiaries (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Syneos Health, Inc. for the year ended December 31, 2017.
/s/ Deloitte & Touche LLP
Raleigh, North Carolina
February 28, 2018